Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT04797702
Status:
UNKNOWN
Last Update Posted:
2021-03-15
First Post:
2021-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer.
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-02-26
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-26
First Submit QC Date:
None
Study First Post Date:
2021-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-10
Last Update Post Date:
2021-03-15
Last Update Post Date Type:
ACTUAL